Elan reveals first quarter results

Elan Corporation today announced its first quarter 2008 financial results and provided a business update indicating positive results.

Commenting on Elan's business, Kelly Martin, Elan's president and chief executive officer, said: 'We continued to demonstrate successful execution and delivery of tangible results in the first quarter. We remain highly focused on advancing our mid to late stage clinical pipeline as well as supporting physicians and their patients in choosing Tysabri in MS and also now in Crohn's.